According to the research report titled ‘Global Sciatica Market Size study, by Types (Acute, Chronic and Others), By Pharmacological Therapies (Non-Steroidal Anti-inflammatory Drug (NSAIDs), Steroids, Antidepressants, Painkillers and Others), and Regional Forecasts 2022-2028’, available with MarketStudyReport, global sciatica market is expected to register a 9.5% CAGR over 2022-2028.

Seasoned analysts cite that ever increasing elderly population, growing public awareness of the disease, and a high sciatica survival rate are the major growth stimulants for global sciatica market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5110080/

For the unversed, sciatica is a condition that affects the sciatic nerve, which goes down from the lower back to the hips and buttocks and down to the legs. Sciatica can cause moderate to severe pain along the sciatic nerve. This happens because a section of the nerve is typically compressed by a herniated disc, a bone spur on the spine, or spinal stenosis.

According to the Centers for Disease Control and Prevention (CDC), three out of five people (58.9%) in the United States experienced pain of some kind in the first three months of 2019, wherein 39% individuals reported having back pain, 36.5% reported having pain in their lower limbs, and 30.7% reported having pain in their upper limbs.

Furthermore, increasing spending on healthcare by individuals will augment industry outlook in the coming years. However, presence of several off-label medications and physical therapy may hamper market trends over the stipulated timeframe.

Based on types, worldwide sciatica marketplace is divided into chronic, acute, and others. In terms of pharmacological therapies, the industry is branched into painkillers, antidepressants, steroids, non-steroidal anti-inflammatory drug, and others.

Regionally, North America market is flourishing at present and is slated to grow at a rapid pace during the analysis timeframe, owing to surge in demand for disease-specific new treatments, and increasing government investments in healthcare in the
region.

Coming to competitive arena, Seikagaku Corp., Vita Sciences LLC, Scilex Holding Company, Kolon Life Science Inc., SpineThera, Aurobindo Pharma Limited, Eliem Therapeutics Inc., Sinfonia Biotherapeutics, and Sorrento Therapeutics Inc. are the major players in global sciatica market.